Stratistics MRC¿¡ µû¸£¸é, ¼¼°è ´ç´¢º´¼º Á·ºÎ ±Ë¾ç Ä¡·á ½ÃÀåÀº 2024³â 90¾ï 2,000¸¸ ´Þ·¯ ±Ô¸ðÀ̸ç, ¿¹Ãø ±â°£ µ¿¾È CAGR 8.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 145¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
´ç´¢º´¼º Á·ºÎ ±Ë¾ç Ä¡·á¿¡´Â ´ç´¢º´°ú °ü·ÃµÈ ÇÕº´ÁõÀ¸·Î ÀÎÇÑ ±Ë¾çÀ» Ä¡·áÇϱâ À§ÇÑ ´Ù¾çÇÑ ÀÇ·á ¹× Ä¡·áÀû °³ÀÔÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Ä¡·á¿¡´Â µå·¹½Ì°ú °°Àº »óó °ü¸®, °¨¿° ¿¹¹æÀ» À§ÇÑ Ç×±ÕÁ¦ »ç¿ë µî ´Ù¾çÇÑ Ä¡·á¹ýÀÌ Æ÷ÇԵǸç, ½ÉÇÑ °æ¿ì¿¡´Â ¼ö¼úÀû Ä¡·á°¡ ÇÊ¿äÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÉÇÑ °æ¿ì¿¡´Â ¿Ü°úÀû ¼ö¼úÀÌ ÇÊ¿äÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀûÀýÇÑ ¹ß °ü¸®¿Í ´ç´¢º´ °ü¸®¿¡ ´ëÇÑ È¯ÀÚ ±³À°Àº ±Ë¾ç Àç¹ßÀ» ¿¹¹æÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ±Ã±ØÀûÀÎ ¸ñÇ¥´Â Ä¡À¯¸¦ ÃËÁøÇϰí ÇÕº´ÁõÀ» ÁÙÀ̸ç ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â °ÍÀÔ´Ï´Ù.
´ç´¢º´ À¯º´·ü Áõ°¡
´ç´¢º´ À¯º´·ü Áõ°¡´Â Á·ºÎ ÇÕº´ÁõÀÇ À§Çè¿¡ óÇÑ È¯ÀÚ ¼ö¸¦ Áõ°¡½ÃÅ´À¸·Î½á ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ´ç´¢º´ ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½Å°æ ¼Õ»ó°ú Ç÷¾× ¼øÈ¯ Àå¾Ö¸¦ °æÇèÇÏ´Â »ç¶÷ÀÌ Áõ°¡ÇÏ¿© Á·ºÎ ±Ë¾ç ¹ß»ý·üÀÌ ³ô¾ÆÁý´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â Ư¼ö »óó °ü¸® Á¦Ç° ¹× Ä¡·á¹ý°ú °°Àº °í±Þ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ½Ã½ºÅÛÀº ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ Á¾ÇÕÀûÀÎ °ü¸® Àü·«À» ½ÃÇàÇØ¾ß Çϸç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
³ôÀº Ä¡·áºñ
³ô¾ÆÁö´Â Ä¡·áºñ´Â ¸¹Àº ȯÀڵ鿡°Ô ÷´Ü Ä¡·á Á¢±Ù¼ºÀ» Á¦ÇÑÇÏ°í ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. Àü¹®ÀûÀÎ »óó °ü¸® Á¦Ç° ¹× ±â¼ú ºñ¿ëÀº Àû½Ã¿¡ °³ÀÔÀ» ¹æÇØÇÏ¿© ÇÕº´ÁõÀ» Áõ°¡½ÃŰ°í º´¼¼¸¦ ¾ÇȽÃų ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °æÁ¦Àû À庮Àº Ä¡·á Áö¿¬À¸·Î À̾îÁ® ±Ã±ØÀûÀ¸·Î ȯÀÚÀÇ ¿¹ÈÄ¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. µû¶ó¼ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù.
±â¼úÀÇ ¹ßÀü
½º¸¶Æ® µå·¹½Ì Àç·á, »ýü Ȱ¼º Àç·á, ¿ø°Ý ÀÇ·á ¼ºñ½º¿Í °°Àº Çõ½ÅÀûÀÎ »óó Ä¡·á ¼Ö·ç¼ÇÀÇ µµÀÔÀ¸·Î ±â¼ú ¹ßÀüÀÌ ½ÃÀå¿¡ º¯È¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº Ä¡·á È¿°ú¸¦ ³ôÀ̰í Á¶±â Ä¡À¯¸¦ ÃËÁøÇϸç ȯÀÚ ¸ð´ÏÅ͸µÀ» °³¼±ÇÕ´Ï´Ù. µ¥ÀÌÅÍ ºÐ¼®°ú ¸ð¹ÙÀÏ °Ç° ¿ëµµÀÇ ÅëÇÕÀº °³ÀÎÈµÈ Ä¡·á¸¦ ÃËÁøÇÏ°í °á°ú¿Í ȯÀÚ Âü¿©¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ¼ºñ½º Á¦°ø¾÷ü°¡ ÀÌ·¯ÇÑ ±â¼úÀ» äÅÃÇÔ¿¡ µû¶ó °í±Þ ´ç´¢º´¼º Á·ºÎ ±Ë¾ç Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
Á¦ÇÑÀûÀÎ ÀÇ·á ¼ºñ½º Á¢±Ù¼º
ÀÇ·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Á¦ÇѵǸé ȯÀÚÀÇ Àû½Ã Áø´Ü°ú °³ÀÔÀ» ¹æÇØÇÏ¿© ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ÀÇ·á ¼ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼´Â ÀÇ·á ½Ã¼³°ú Àü¹® ÀÇ·á ¼ºñ½º°¡ ºÎÁ·ÇÏ¿© Ä¡·á°¡ Áö¿¬µÇ°í, °¨¿°À̳ª Àý´Ü°ú °°Àº ÇÕº´Áõ À§ÇèÀÌ ³ô¾ÆÁý´Ï´Ù. ÀÌ·¯ÇÑ ½Ã³ª¸®¿À´Â ȯÀÚ °á°úÀÇ ¾ÇÈ¿Í Àå±âÀûÀÎ ÀÇ·áºñ Áõ°¡·Î À̾îÁ® ´ç´¢º´¼º Á·ºÎ ±Ë¾çÀÇ È¿°úÀûÀÎ °ü¸®¸¦ º¸ÀåÇϱâ À§ÇØ ÀÇ·á ÀÎÇÁ¶ó ¹× Á¢±Ù¼º °³¼±ÀÇ Çʿ伺À» °Á¶ÇÏ°í ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀÔ´Ï´Ù.
Äڷγª19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ¼±ÅÃÀû ½Ã¼úÀÌ Áö¿¬µÇ°í Æó¼â·Î ÀÎÇØ ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ È¯ÀÚ ¹æ¹®ÀÌ °¨¼ÒÇÏ¸é¼ ´ç´¢º´¼º Á·ºÎ±Ë¾ç Ä¡·á ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀÌ´Â ´ç´¢º´ ȯÀÚÀÇ ÇÕº´Áõ Áõ°¡¿Í Áúº´ »óÅ ¾ÇÈ·Î À̾îÁý´Ï´Ù. ±×·¯³ª ÀÌ À§±â´Â ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼ú Çõ½ÅÀ» ÃËÁøÇÏ¿© Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½ÃÄ×½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ½Å°æº´¼º ±Ë¾ç ºÐ¾ß°¡ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½Å°æº´¼º ±Ë¾çÀº Á¾Á¾ ½Å°æ ¼Õ»óÀ¸·Î ÀÎÇØ °¨°¢ ÀúÇÏ¿Í ÀÎÁöÇÏÁö ¸øÇÏ´Â ºÎ»óÀ¸·Î À̾îÁö±â ¶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È ½Å°æº´¼º ±Ë¾ç ºÐ¾ß°¡ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Å°æº´¼º ±Ë¾çÀÇ À¯º´·ü Áõ°¡´Â Àü¹®ÀûÀÎ Ä¡·á¿Í °í±Þ Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ÀÇ·á ¼ºñ½º Á¦°ø¾÷üµéÀÌ Á¤±âÀûÀÎ °ËÁø ¹× ¸ÂÃãÇü Ä¡·á¿Í °°Àº Á¾ÇÕÀûÀÎ °ü¸® Àü·«¿¡ ÃÊÁ¡À» ¸ÂÃß¸é¼ ´ç´¢º´¼º Á·ºÎ ±Ë¾ç Ä¡·á ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î ¼ºÀåÇϰí ÀÖÀ¸¸ç, ȯÀÚ Ä¡·á¿¡¼ ½Å°æº´¼º Áúȯ¿¡ ´ëÇÑ ´ëÀÀÀÇ Á߿伺ÀÌ °Á¶µÇ°í ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È º´¿ø ºÎ¹®ÀÌ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º´¿ø ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµÇ´Âµ¥, ÀÌ´Â Á·º´ÇÐ, »óó °ü¸®, ´ç´¢º´ °ü¸® µî ´ÙÇÐÁ¦Àû Á¢±Ù¿¡ ´ëÇÑ ÁýÁßÀûÀÎ ³ë·ÂÀ¸·Î ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±Çϱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, º´¿øÀº Á¶±â °³ÀÔ°ú ¿¹¹æ ÀÇ·áÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀÌ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÷´Ü ±â¼ú ¹× »óó °ü¸® Á¦Ç°¿¡ ´ëÇÑ ÅõÀÚ´Â ½ÃÀåÀÇ Çõ½ÅÀ» ÃËÁøÇϰí ÀÇ·á ½Ã½ºÅÛ Àü¹Ý¿¡¼ ´ç´¢º´¼º Á·ºÎ ±Ë¾ç Ä¡·áÀÇ Á¢±Ù¼º°ú È¿À²¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.
ºÏ¹Ì´Â ´ç´¢º´°ú ±× ÇÕº´Áõ ¹ßº´·ü Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Çõ½ÅÀûÀÎ Ä¡·á¹ý°ú ÷´Ü »óó °ü¸® ±â¼úÀº ȯÀÚ °ü¸®¸¦ °³¼±ÇÏ°í °¨¿°°ú Àý´Ü À§ÇèÀ» ÁÙÀÓÀ¸·Î½á ȯÀÚ °ü¸®¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº È¿°úÀûÀÎ Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½ÃÄÑ ±Ã±ØÀûÀ¸·Î ȯÀÚÀÇ »îÀÇ Áú Çâ»óÀ¸·Î À̾îÁú °ÍÀÔ´Ï´Ù. ÀÇ·á ¼ºñ½º Á¦°ø¾÷üÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿¹¹æÀû Ä¡·á¿Í Àû½Ã °³ÀÔÀÇ Á߿伺ÀÌ ´õ¿í °Á¶µÇ°í ÀÖÀ¸¸ç, ÀÌ Áö¿ª¿¡¼ ´ç´¢º´¼º Á·ºÎ ±Ë¾ç °ü¸®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Àå·ÁÇϰí ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀº ´ç´¢º´ ¹× °ü·Ã ÇÕº´Áõ À¯º´·ü Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀûÀýÇÑ ¹ß °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í Ä¡·á ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó È¿°úÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´ç´¢º´ °ü¸® ¹× ÀÇ·á ÀÎÇÁ¶ó °³¼±À» À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê´Â Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº °í·ÉÈ Àα¸ Áõ°¡¿Í ºñ¸¸ À¯º´·ü Áõ°¡·Î ÀÎÇØ ´õ¿í °¡¼Óȵǰí ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Diabetic Foot Ulcer Treatment Market is accounted for $9.02 billion in 2024 and is expected to reach $14.55 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Diabetic foot ulcer treatment encompasses a range of medical and therapeutic interventions aimed at healing ulcers resulting from diabetes-related complications. These treatments include wound care management, such as debridement and the application of advanced dressings, as well as the use of antimicrobial agents to prevent infection. In severe cases, surgical interventions may be necessary. Additionally, patient education on proper foot care and diabetes management plays a vital role in preventing ulcer recurrence. The ultimate goal is to promote healing, reduce complications, and enhance the quality of life for affected individuals.
Rising Diabetes Prevalence
Rising diabetes prevalence significantly impacts the market by increasing the number of patients at risk for foot complications. As diabetes cases grow, more individuals experience neuropathy and poor circulation, leading to a higher incidence of foot ulcers. This trend drives demand for advanced treatment options, including specialized wound care products and therapies. Additionally, healthcare systems are compelled to implement comprehensive management strategies to address these challenges, further fueling market growth.
High Treatment Costs
High treatment costs significantly impact the market by limiting access to advanced therapies for many patients. The expense associated with specialized wound care products and technologies can discourage timely intervention, leading to increased complications and worsening conditions. This financial barrier may result in delayed treatment, ultimately affecting patient outcomes. Thus, it hinders the growth opf the market.
Advancements in Technology
Advancements in technology are transforming the market by introducing innovative wound care solutions, such as smart dressings, bioactive materials, and telehealth services. These technologies enhance the effectiveness of treatment, promote faster healing, and allow for better patient monitoring. The integration of data analytics and mobile health applications facilitates personalized care, improving outcomes and patient engagement. As healthcare providers increasingly adopt these technologies, the demand for advanced diabetic foot ulcer treatments grows, thus it drives the growth of the market.
Limited Healthcare Access
Limited healthcare access impacts the market by hindering timely diagnosis and intervention for patients. In underserved regions, a lack of medical facilities and specialized care can result in delayed treatments, increasing the risk of complications like infections and amputations. This scenario leads to poorer patient outcomes and higher long-term healthcare costs, emphasizing the need for improved healthcare infrastructure and accessibility to ensure effective management of diabetic foot ulcers, thus it hampers the growth of the market.
The COVID-19 pandemic adversely affected the diabetic foot ulcer treatment market by causing delays in elective procedures and reducing patient visits to healthcare facilities due to lockdowns. This leads to increased complications and worsening conditions among diabetic patients. However, the crisis also spurred innovation in telehealth and remote monitoring, improving access to care.
The neuropathic ulcers segment is expected to be the largest during the forecast period
The neuropathic ulcers segment is expected to be the largest during the forecast period as these ulcers often result from nerve damage, leading to reduced sensation and unrecognized injuries. The growing prevalence of neuropathic ulcers drives demand for specialized treatments and advanced care solutions. As healthcare providers focus on comprehensive management strategies, including regular screening and tailored therapies, the market for diabetic foot ulcer treatments continues to expand, emphasizing the importance of addressing neuropathic conditions in patient care.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals segment is expected to have the highest CAGR during the forecast period because Increased focus on multidisciplinary approaches, including podiatry, wound care, and diabetes management, enhances patient outcomes. Hospitals are also instrumental in raising awareness about the importance of early intervention and preventative care. Moreover, their investment in advanced technologies and wound care products drives innovation in the market, improving accessibility and efficiency in treating diabetic foot ulcers across the healthcare system.
North America is projected to hold the largest market share during the forecast period as it addresses the rising incidence of diabetes and its complications. Innovative therapies and advanced wound care technologies improve patient management, reducing the risk of infections and amputations. This market's growth enhances access to effective treatments, ultimately leading to better patient quality of life. Increased awareness among healthcare providers further emphasizes the importance of preventative care and timely intervention, fostering a comprehensive approach to managing diabetic foot ulcers in the region.
Asia Pacific is projected to witness the highest CAGR over the forecast period owing to rising prevalence of diabetes and related complications. Increasing awareness of proper foot care and advancements in treatment technologies are driving demand for effective therapies. Additionally, government initiatives aimed at improving diabetes management and healthcare infrastructure are enhancing access to treatments. This growth is further supported by the expanding aging population and the increasing incidence of obesity.
Key players in the market
Some of the key players in Diabetic Foot Ulcer Treatment Market include 3M Healthcare, Acelity L.P. Inc. (KCI), Advanced Tissue, Alliqua Biomedical, Inc., B. Braun Melsungen AG, BSN Medical GmbH, Cardinal Health, Inc., Coloplast A/S, ConvaTec Group Plc, Derma Sciences Inc., Hollister Incorporated, Integra LifeSciences Corporation, Medline Industries, Inc., Medtronic Plc, Molnlycke Health Care AB, Organogenesis Inc., Osiris Therapeutics, Inc., Paul Hartmann AG, Smith & Nephew Plc and Wound Care Innovations, LLC.
In August 2024, Cardinal Health expanded medical product distribution footprint in Northeast Ohio, to support its U.S. Medical Products and Distribution business.
In November 2023, Cardinal Health announced the U.S. launch of its SmartGown EDGE Breathable Surgical Gown with ASSIST Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room.
In September 2023, Cardinal Health announced the U.S. launch of its Kangaroo OMNI Enteral Feeding Pump, designed to help provide enteral feeding patients with more options to meet their personalized needs throughout their enteral feeding journey.